A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
Zhuolong Zhou(University of Indianapolis), Xiongbin Lu(The University of Texas MD Anderson Cancer Center)
Cited by 55
Related Papers
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
|Genes & Development|2005|383
ST2 as checkpoint target for colorectal cancer immunotherapy
|JCI Insight|2020|52